Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BBOX1 | O75936 | 11/20 | 0.64 |
| ▸ | ACHE | P22303 | 2/20 | 0.61 |
| ▸ | CA1 | P00915 | 1/20 | 0.50 |
| ▸ | FFAR3 | O14843 | 1/20 | 0.43 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.43 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.43 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.43 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.43 |
| ▸ | MEN1 | O00255 | 2/20 | 0.43 |
| ▸ | NFKB1 | P19838 | 2/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.43 |
| ▸ | LMNA | P02545 | 1/20 | 0.43 |
| ▸ | APEX1 | P27695 | 1/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.43 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.43 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.43 |
| ▸ | TSHR | P16473 | 1/20 | 0.43 |
| ▸ | RAB9A | P51151 | 1/20 | 0.43 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL25181735 | 0.97 | BBOX1 (0.61) | BBOX1ACHECA1FFAR3HDAC3 | |
| SCHEMBL14352035 | 0.92 | BBOX1 (0.56) | BBOX1ACHECA1MEN1NFKB1 | |
| Valeric Acid SCHEMBL5573570 | 0.86 | CA1 (0.67) | BBOX1ACHECA1FFAR3HDAC3 | |
| Hexanoate SCHEMBL5571735 | 0.84 | CA1 (0.58) | BBOX1CA1NFKB1 | |
| Valeric Acid SCHEMBL5574325 | 0.84 | CA1 (0.64) | BBOX1CA1NFKB1 | |
| Hexanoate SCHEMBL5574422 | 0.84 | CA1 (0.58) | BBOX1CA1 | |
| SCHEMBL3497626 | 0.83 | — | — | |
| Glutarate SCHEMBL17982129 | 0.83 | MEN1 (0.52) | BBOX1ACHECA1MEN1KMT2A | |
| Hexanoate SCHEMBL5574315 | 0.83 | DNM1 (0.60) | CA1 | |
| Stearic Acid SCHEMBL4942597 | 0.83 | DNM1 (0.60) | CA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1544 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4747627-A1 | METHODS AND SYSTEMS FOR PREDICTIVE CLASSIFICATION BY MASS SPECTROMETRY AND TRAINED LARGE SPECTRAL MODELS | Matterworks Inc (US) | 2026-05-27 | — | — | EP | claimed |
| US-20250302964-A1 | Topical Compositions and Methods for Treatment of Diabetic Neuropathies | CROSS III WILLIAM H (US) | 2025-10-02 | — | — | US | claimed |
| EP-4260070-B1 | DIAGNOSIS OF AUTISM SPECTRUM DISORDER | STALICLA S A (CH) | 2025-09-24 | — | — | EP | claimed |
| US-12329818-B2 | Topical compositions and methods for treatment of diabetic neuropathies | CROSS III WILLIAM H (US) | 2025-06-17 | — | — | US | claimed |
| WO-2025019764-A1 | METHODS AND SYSTEMS FOR PREDICTIVE CLASSIFICATION BY MASS SPECTROMETRY AND TRAINED LARGE SPECTRAL MODELS | MATTERWORKS INC (US) | 2025-01-23 | — | — | WO | claimed |
| WO-2024243289-A2 | GUT MICROBE DERIVED AROMATIC AMINO ACID METABOLITES FOR DETECTION AND TREATMENT OF DISEASE | THE CLEVELAND CLINIC FOUNDATION (US) | 2024-11-28 | — | — | WO | claimed |
| US-20240385183-A1 | METABOLIC AND MICROBIAL BIOMARKERS FOR DETECTION OF PANCREATICOBILIARY CANCERS | NORTHWESTERN UNIVERSITY | 2024-11-21 | — | — | US | claimed |
| EP-4437319-A1 | METHODS AND COMPOSITIONS FOR ANALYTE QUANTIFICATION | Matterworks Inc (US) | 2024-10-02 | — | — | EP | claimed |
| US-20240293300-A1 | SKIN PENETRATION COSMETIC MATERIAL, AND SKIN PENETRATION COSMETIC MATERIAL PRODUCTION METHOD | SHISEIDO COMPANY, LTD. (JP) | 2024-09-05 | — | — | US | claimed |
| CN-118443857-A | Lipid metabolism marker for distinguishing wild and cultivated four-big domestic fish and application thereof | 中国水产科学研究院长江水产研究所 | 2024-08-06 | — | — | CN | claimed |
| WO-1994028780-A2 | METHODS OF PREPARING GAS AND GASEOUS PRECURSOR-FILLED MICROSPHERES | UNGER EVAN C (US) | 1994-12-22 | — | — | WO | claimed |
| WO-1994028874-A1 | NOVEL THERAPEUTIC DELIVERY SYSTEMS | UNGER EVAN C (US) | 1994-12-22 | — | — | WO | claimed |
| EP-0360222-B1 | PROCESS FOR PREPARING GAMMA-BUTYROBETAINE | LONZA AG (CH) | 1993-03-10 | — | — | EP | claimed |
| US-5087745-A | PROCESS FOR THE PRODUCTION OF GAMMA-BUTYROBETAINE | LONZA LTD. (CH) | 1992-02-11 | — | — | US | claimed |
| US-5030458-A | Administering gamma-butyrobetaine | SHUG AUSTIN L (US) | 1991-07-09 | — | — | US | claimed |
| EP-0158194-B1 | PROCESS FOR THE PRODUCTION OF L-CARNITINE IN A MICROBIOLOGICAL WAY | LONZA AG (CH) | 1991-06-05 | — | — | EP | claimed |
| EP-0244370-B1 | PROCESS FOR PREPARING GAMMA BUTYROBETAINE | Sigma-Tau Industrie Farmaceutiche Riunite S.p.A. (IT) | 1990-09-19 | — | — | EP | claimed |
| US-4806282-A | CATALYTIC HYDROGENATION OF CROTONOYLBETAINE CHLORIDE | SIGMA-TAU INDUSTRIE FARMACEUTICHE RIUNITE S.P.A. (IT) | 1989-02-21 | — | — | US | claimed |
| EP-0244370-A2 | Process for preparing gamma butyrobetaine | Sigma-Tau Industrie Farmaceutiche Riunite S.p.A. (IT) | 1987-11-04 | — | — | EP | claimed |
| US-4382092-A | Pharmaceutical composition comprising gamma-butyrobetaine for the treatment of syndromes induced by L-carnitine deficiency | SIGMA-TAU INDUSTRIE FARMACEUTICHE RIUNITE S.P.A. (IT) | 1983-05-03 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240293300-A1 | SKIN PENETRATION COSMETIC MATERIAL, AND SKIN PENETRATION COSMETIC MATERIAL PRODUCTION METHOD | CUTA, SLC6A12, DSG1 | BBOX1 40/4885ACHE 855/4885CA1 4323/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.